Market Overview

UPDATE: Jefferies Upgrades Health Management Associates to Buy on Multiple Expansion, Reform Momentum

Related HMA
Benzinga's Volume Movers
US Stock Futures Rise Ahead Of International Trade Data

Jefferies upgraded Health Management Associates (NYSE: HMA) from Hold to Buy and raised the price target from $7.50 to $14.50.

Jefferies analyst Brian Tanquilut commented, "We believe HMA shares still have meaningful upside left despite the stock's recent run given our view that sector multiples will continue to expand as key reform provisions take shape over the course of the next few months. As Medicaid expansion gains steam, especially in GOP-dominated states, and "exchange" pricing visibility improves, we expect HMA stock to continue rising."

Health Management Associates closed at $12.26 on Friday.

Latest Ratings for HMA

DateFirmActionFromTo
Dec 2013Wells FargoDowngradesOutperformMarket Perform
Sep 2013Avondale PartnersDowngradesMarket OutperformMarket Perform
Aug 2013UBSDowngradesBuyNeutral

View More Analyst Ratings for HMA
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Upgrades Analyst Ratings

 

Related Articles (HMA)

Around the Web, We're Loving...

Get Benzinga's Newsletters